Rhythm AI

RHYTHM AI announces FDA clearance of the commercial release version of STAR Apollo Mapping System

First-in-human cases successfully completed using this new system at Baptist Health, Jacksonville, Florida 23 September 2024, – London, UK – RHYTHM AI Ltd (“RHYTHM AI” or “the Company”), a UK company focused on optimizing Atrial Fibrillation (AF) procedures, announces US Food and Drug Administration (FDA) 510k clearance for the commercial launch version of its lead...